Evaluation of oral zinc therapy in Acne Vulgaris disease

Determination of the Effect of Oral zinc therapy on the Treatment of Acne vulgaris in Patients with Grade 2 and 3 Acne vulgaris

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190505043485N1

Enrollment

100

Registered

2019-06-01

Start date

2019-05-11

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris. Acne vulgaris

Interventions

Intervention 1: Intervention group: Patients in the intervention group in addition to the routine treatment of Acne Vulgaris (containing 1% topical Clindamycin gel and 1% topical Salicylic Acid gel) w

Eligibility

Sex/Gender

All

Age

15 Years to 40 Years

Inclusion criteria

Inclusion criteria: 2nd and 3rd grade of Acne Vulgaris patients depends on Pillsburg classification

Exclusion criteria

Exclusion criteria: The patients with Gastrointestinal disorder The pregnant patients and breast feeding mothers Using other topical and oral anti Acne drugs Patients with Grade 1 and 4 Acne Vulgaris Female patients with hormonal disorders Patients with oral Isotretinoin in the last 3 months

Design outcomes

Primary

Measure	Time frame
Reduce in number of Acne. Timepoint: Evaluation the number of Acne in 14 days. Method of measurement: Observational.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Marziyeh Afrouzandeh

Boushehr University of Medical Sciences

marzieh642004@yahoo.com+98 77 3345 5490

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026